Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Rating) was the target of a significant growth in short interest in March. As of March 31st, there was short interest totalling 4,940,000 shares, a growth of 25.1% from the March 15th total of 3,950,000 shares. Based on an average trading volume of 1,290,000 shares, the short-interest ratio is […]
Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Rating) was the recipient of a large increase in short interest in March. As of March 31st, there was short interest totalling 4,940,000 shares, an increase of 25.1% from the March 15th total of 3,950,000 shares. Based on an average trading volume of 1,290,000 shares, the short-interest ratio is […]
A young geneticist, Dr Rais A Gania was surprised to see his takeaways from his PhD were part of the text well before he entered the classroom as a teacher. Credited for identifying a particular enzyme that helps in crucial DNA copying, he is serving the IUST’s molecular medicine centre.
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.